Yr Athro Mererid Evans

2024

• O’Hara, J. T. et al. 2024. Transoral laser or robotic surgery outcomes for oropharyngeal carcinoma. JAMA Otolaryngology-Head and Neck Surgery 150(11), pp. 1002-1011. (10.1001/jamaoto.2024.3371)
• Fuentes, J. D. B. et al. 2024. High-grade neuroendocrine head and neck cancer: Case series and review of the literature. Current Problems in Cancer 51, article number: 101105. (10.1016/j.currproblcancer.2024.101105)
• Thomson, D. et al. 2024. Randomised phase III trial of the hypoxia modifier nimorazole added to radiotherapy with benefit assessed in hypoxic head and neck cancers determined using a gene signature (NIMRAD). International Journal of Radiation Oncology - Biology - Physics 119, pp. 771-782. (10.1016/j.ijrobp.2023.11.055)

2019

• Jadon, R., Higgins, E., Hanna, L., Evans, M., Coles, B. and Staffurth, J. 2019. A systematic review of dose-volume predictors and constraints for late bowel toxicity following pelvic radiotherapy. Radiation Oncology 14(1), pp. -., article number: 57. (10.1186/s13014-019-1262-8)

2018

• Pirotte, E. F. et al. 2018. Sensitivity to inhibition of DNA repair by Olaparib in novel oropharyngeal cancer cell lines infected with Human Papillomavirus. PLoS ONE 13(12), pp. -., article number: e0207934. (10.1371/journal.pone.0207934)
• Parkinson, C. et al. 2018. Target volume delineation of FDG PET images post one cycle of induction chemotherapy in oropharyngeal cancer using advanced automated segmentation methods. Presented at: ESTRO 37, Barcelona, 20-24 April 2018.